DALEY GEORGE Q has a total of 14 patent applications. Its first patent ever was published in 2001. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and United States. Its main competitors in its focus markets pharmaceuticals, machines and biotechnology are QUAY STEVEN C, NEW YORK MEDICAL COLLEGE and APPLIED GENETICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 3 | |
#2 | Australia | 2 | |
#3 | United States | 2 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Mexico | 1 | |
#9 | Norway | 1 | |
#10 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Biotechnology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Unspecified technologies | |
#4 | Measuring microorganism processes | |
#5 | Microorganisms | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Daley George Q | 14 |
#2 | Park In-Hyun | 1 |
#3 | Raz Tal | 1 |
#4 | Azam Mohammad | 1 |
#5 | Hoover Russell R | 1 |
#6 | Ratanasirintrawoot Sutheera | 1 |
#7 | Schlaeger Thorsten M | 1 |
#8 | Chan Elayne | 1 |
Publication | Filing date | Title |
---|---|---|
WO2018232079A1 | Hematopoietic stem and progenitor cells derived from hemogenic endothelial cells by episomal plasmid gene transfer | |
US2009181369A1 | Methods for the Treatment of Disease | |
AU1186202A | Methods of inducing cancer cell death and tumor regression |